2018
Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review
Moore KE, Roberts W, Reid HH, Smith KMZ, Oberleitner LMS, McKee SA. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review. Journal Of Substance Use And Addiction Treatment 2018, 99: 32-43. PMID: 30797392, PMCID: PMC6391743, DOI: 10.1016/j.jsat.2018.12.003.Peer-Reviewed Original ResearchMeSH KeywordsBuprenorphineHumansMethadoneNaltrexoneOpiate Substitution TreatmentOpioid-Related DisordersPrisonsRandomized Controlled Trials as TopicRecidivismRisk-TakingConceptsIllicit opioid useOpioid useEffectiveness of medicationsHealth risk behaviorsTreatment engagementNaltrexone studiesQuasi-experimental studyRisk behaviorsCommunity substanceInjection drug useCorrectional settingsObservational studyMethadonePubMed databaseDrug useSystematic reviewMedicationsJail settingsConsistent findingBuprenorphineRCTsUse of MATIndividual reviewsTreatmentMeta-analytic summary
2015
Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis
McKee SA, Smith PH, Kaufman M, Mazure CM, Weinberger AH. Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis. Nicotine & Tobacco Research 2015, 18: 1002-1011. PMID: 26446070, PMCID: PMC5942618, DOI: 10.1093/ntr/ntv207.Peer-Reviewed Original ResearchMeSH KeywordsAdultFemaleHumansMaleNicotinic AgonistsRandomized Controlled Trials as TopicSex FactorsSmoking CessationSmoking PreventionVareniclineConceptsSmoking cessation medicationsCessation medicationsSmoking cessationDouble-blind placebo-controlled trialEfficacy of vareniclinePlacebo-controlled trialShort-term outcomesClinical trial dataSex differencesSimilar ratesWeek 52Week 24Women smokersNicotine replacementWeek 12Outcome endpointsTherapeutic responseClinical trialsContinuous abstinenceVarenicline's efficacyVareniclinePlacebo outcomesEqual efficacySex disparitiesEffective FDA
2010
Examining antidepressant drug response by smoking status: why is it important and how often is it done?
Weinberger AH, McKee SA, Picciotto MR, Mazure CM. Examining antidepressant drug response by smoking status: why is it important and how often is it done? Journal Of Psychopharmacology 2010, 25: 1269-1276. PMID: 21169392, PMCID: PMC3256572, DOI: 10.1177/0269881110389347.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAntidepressive AgentsDepressionDisease Models, AnimalHumansRandomized Controlled Trials as TopicSmokingConceptsSmoking statusImpact of smokingEffect of smokingNeurobiology of depressionAntidepressant treatment outcomeAntidepressant drug responsePharmacological intervention studiesPharmacological trialsClinical trialsTreatment outcomesMEDLINE searchNicotine dependenceSmokingTargeted treatmentIntervention studiesTreatment studiesDrug responseDepressionOutcomesTreatment researchTrialsStatusTreatmentAntidepressantsPharmacotherapyInclusion of Women and Gender-Specific Analyses in Randomized Clinical Trials of Treatments for Depression
Weinberger AH, McKee SA, Mazure CM. Inclusion of Women and Gender-Specific Analyses in Randomized Clinical Trials of Treatments for Depression. Journal Of Women's Health 2010, 19: 1727-1732. PMID: 20799923, PMCID: PMC2936499, DOI: 10.1089/jwh.2009.1784.Peer-Reviewed Original ResearchMeSH KeywordsAdultDepressionDepressive DisorderFemaleHumansMalePatient SelectionRandomized Controlled Trials as TopicSex FactorsConceptsRecent randomized clinical trialsRandomized clinical trialsClinical trialsGender-specific analysisDepression treatmentHealth (NIH) Revitalization ActCost of depressionInterventional studyInclusion of womenHigh prevalenceTreatment responseMEDLINE searchTreatment efficacyGender differencesPossible gender differencesDepression researchTrialsWomenDepressionNational InstituteRevitalization ActTreatmentFemale participantsOutcomesGender
2008
Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder
Leeman RF, McKee SA, Toll BA, Krishnan-Sarin S, Cooney JL, Makuch RW, O'Malley SS. Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine & Tobacco Research 2008, 10: 1793-1809. PMID: 19023831, PMCID: PMC2764010, DOI: 10.1080/14622200802443742.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAlcohol DrinkingAlcoholismComorbidityFemaleHumansMaleMiddle AgedMotivationRandomized Controlled Trials as TopicRecurrenceRisk FactorsSeverity of Illness IndexSmokingSmoking CessationSmoking PreventionTreatment FailureConceptsHeavy drinking daysAlcohol use disorderAUD historyCessation relapseUse disordersDrinking daysModerate drinkingAlcohol useSustained-release bupropionLifetime alcohol use disorderModerate alcohol usersRandomized clinical trialsAlcohol use categoriesProbability of smokingSmoking cessation failureTreatment failureAlcohol use levelsRisk factorsClinical trialsHazardous patternsTreatment periodHazardous drinkersAbstinent daysCessation failureAlcohol users